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Summary
Objective: To identify the effect of ﬁbroblastic growth factor-2 (FGF-2) on the intrinsic damageerepair response in articular cartilage in vitro.
Methods: Articular equine cartilage explants, without subchondral bone, had a single impact load of 500 g applied from a height of 2.5 cm.
Explants were then cultured in 0, 12, 25, 50 or 100 ng/ml FGF-2 for up to 28 days. Unimpacted discs served as controls for each time-point.
Histological and immunohistochemical techniques were used to quantify and characterise the response of putative chondrocyte progenitor
cells (CPC) to damage and FGF-2 treatment.
Results: FGF-2 signiﬁcantly accelerated the appearance and increased the numbers of de novo repair cells identiﬁed histologically at the
cartilage surface. The response was affected by the dose of FGF-2. The repair cells were shown to be chondrocytes by their expression of
collagen types II, IX/XI, but not of type I collagen. In addition, these cells, and those underlying the articular surface, were shown to be
immunopositive for Notch-1 and PCNA, markers for proliferating cartilage progenitor cells.
Conclusions: The results of this study indicate that, following single impact load, CPC can be stimulated in mature articular cartilage in vitro.
These CPC and the cells arising from them appear to represent the cartilage’s response to damage. The timing of the appearance of CPC and
their overall numbers can be signiﬁcantly increased by FGF-2, providing further evidence for an important role for FGF-2 in modulating
cartilage repair. These results indicate that further study into the mechanisms of repair in mature cartilage using this in vitro model are vital in
understanding the repair capacity of mature cartilage.
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Cartilage
Repair
SocietyIntroduction
Defects in articular cartilage are classiﬁed as full or partial
thickness, depending on whether the underlying subchon-
dral bone is penetrated. Full thickness defects recruit bone
mesenchymal stem cells to achieve fully functional heal-
ing1, whilst partial thickness defects are considered unable
to repair and form mature hyaline cartilage2e5.
Despite a widely held previous belief that mature cartilage
does not possess cartilage progenitor cells (CPC)5, direct
evidence for a CPC population has recently been reported6.
These authors described the isolation of CPC from the
surface zone of articular cartilage and their phenotypic
plasticity in an embryonic chick plasticity tracking system.
CPC have also been identiﬁed indirectly in normal2 and
diseased cartilage7 and in isolated chondrocyte popula-
tions5,8,9,10.
We have recently observed a novel intrinsic damagee
repair response in mature articular cartilage explants
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This response was characterised by the appearance of
de novo cells on the impacted surfaces of cartilage. These
cells were chondrocytes, as demonstrated by their positive
immunostaining for chondrocytic markers including colla-
gen types II, IX/XI and ﬁbronectin, indicating that they may
be the products of CPC expansion and cell migration12. In
order to further identify the mechanism leading to the
appearance of these de novo cells it was considered
important to determine the effect of possible modulators.
Although much research has focussed on the chondro-
genic effects of growth factors, particularly transforming
growth factor-beta (TGF-b), insulin-like growth factor-1
(IGF-1) and the bone morphogenic proteins (BMPs)13,14,
relatively few studies have recognised the importance of
ﬁbroblastic growth factor-2 (FGF-2). FGF-2 is regarded as
a potent mitogen for chondrocytes in vitro15 and a number
of studies have demonstrated that FGF-2 may be involved
in the cartilaginous repair response in full thickness articular
cartilage defects16e19. FGF-2 is known to have a proven
role in the control of bone-marrow derived stem cells,
allowing their in vitro expansion and maintenance as
chondro-osteo-progenitor cells20, and Hiraki et al.18 sug-
gested that, in a full thickness defect repair model, FGF-2
may stimulate a selective expansion of CPC.
In addition to an involvement in the modulation of
connective tissue progenitor cell behaviour, recent in vitro
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signalling following loading damage21,22, making it a good
candidate for involvement in repair of mechanically induced
damage. The aim of this study was to investigate the effects
of FGF-2 on de novo cell numbers in a single impact load
model of intrinsic damageerepair response in articular
cartilage.
Materials and methods
COLLECTION OF SAMPLES
Cartilage was obtained from horses (nZ 8, age range
18 monthse16 years) that were humanely destroyed for
reasons other than orthopaedic disease. Discs of articular
cartilage (7 mm diameter) were aseptically harvested using
a cork borer from the trochlear ridges of the distal tibia and
from the lateral and medial trochlear ridges of the distal
femur. The depth of the discs was approximately 1 mm, and
included all zones of the cartilage from the articular surface
to the deep zone down to, but not including, subchondral
bone. All explants were immediately placed into sterile
phosphate buffered saline (PBS) containing antibiotics and
antimycotics (200 IU/ml penicillin, 2.5 mg/ml fungizone,
100 mg/ml streptomycin), then washed 3 times in sterile PBS.
SINGLE IMPACT LOADING
Cartilage was impacted using a drop tower device as
described by Bowe et al.23. Samples were impacted with
0.175 J at 0.7 m/s (500 g dropped from 2.5 cm24), corre-
sponding to a nominal stress of approximately 8 MPa25.
Unimpacted discs served as controls.
CULTURE OF CARTILAGE DISCS
After impact, explants were cultured for 1, 3, 5, 7, 10, 20
and 28 days in Dulbecco’s Modiﬁed Eagles Medium
(DMEM) containing 10% foetal calf serum and antibiotics
and antimycotics as detailed above. Explants were divided
into four groups: untreated, impacted and non-impacted
controls and impacted and non-impacted FGF-2 supple-
mented groups to which recombinant human FGF-2
(Sigma, UK) was added to a ﬁnal concentration of 12, 25,
50 or 100 ng/ml. The FGF-2 treatment was continuous,
medium with freshly added FGF-2 being changed every 7
days, to avoid unnecessary disturbance of the cartilage
explants. Following culture, cartilage discs were either
placed into 4% formal saline solution and processed for
routine histological examination or embedded in Tissue Tek
OCT and snap-frozen in liquid nitrogen. Parafﬁn and
cryostat sections (7 mm) were used in histological and
immunohistochemical studies.
HISTOLOGICAL ANALYSIS
Sections were stained with Haematoxylin & Eosin (H&E)
or Toluidine blue. Routine light microscopy was used to
demonstrate cartilage architecture, the extent of cartilage
damage, changes in chondrocyte morphology and to
estimate proteoglycan (PG) content within the extra-cellular
matrix (ECM).
DE NOVO CELL QUANTIFICATION
The appearance of de novo cells was quantiﬁed by
manually counting the number of de novo cells per !20ﬁeld at three separate, randomly selected places on the
articular surface per section at each experimental time-point
in each animal. Values were expressed as mean numbers
(Gstandard deviation) of de novo cells observed at the
articular surface. A paired Student’s t test was used to
establish statistical signiﬁcance between groups.
IMMUNOHISTOCHEMICAL ANALYSIS
Immunohistochemical analysis was performed as de-
scribed previously11,26. The following primary antibodies
were used; polyclonal rabbit anti-rat collagen IX/XI (Calbio-
chem), polyclonal rabbit anti-porcine type II collagen,
polyclonal mouse anti-bovine collagen I (SigmaeAldrich)
and monoclonal mouse anti-proliferating nuclear antigen
(PCNA) (SigmaeAldrich) and goat anti-human Notch-1
(Santa Cruz). Horseradish peroxidase-conjugated second-
ary anti-rabbit, mouse and goat immunoglobulins were used
as appropriate, and the colour reaction developed with
0.1% 3#,3-diaminobenzidine tetrachloride (DAB)/0.01%
hydrogen peroxide. Normal species-speciﬁc serum was
used as a control in all experiments.
Results
CARTILAGE DAMAGE FOLLOWING IMPACT LOAD
Following dissection, single impact load and subsequent
culture, cartilage showed characteristic damage at the
articular surfaces. The damage pattern immediately post-
impact was found to be variable across the surface of the
impacted cartilage and included mild, intermittent surface
roughening with little loss of metachromatic PG staining
[Fig. 1(A)], isolated 45( ﬁssures with slight PG loss
[Fig. 1(B)] and multiple 90( mini-ﬁssures [Fig. 1(C)].
Between the damage sites the cartilage appeared histolog-
ically normal. All control, unimpacted cartilage samples
presented a smooth, intact articular surface along the entire
length of the explant, with uniform metachromatic staining
and no loss of PG [Fig. 1(D)]. This typical pattern seen
immediately after impact did not change during culture and
was similar in cartilage from different sites and from different
aged animals, within the range used in this study.
HISTOLOGICAL APPEARANCE OF ENDOGENOUS REPAIR
RESPONSE IN CARTILAGE
Cartilage samples that had been impacted and then
cultured showed evidence of a repair response after 10
days in culture. At this time small numbers of de novo cells
were observed at the articular surface. No such cells were
seen at 10 days in unimpacted controls. With increasing
time in culture (approximately 20 days) cell numbers
increased and cells were found accumulated particularly
at sites of ﬁssure formation [Fig. 2(A)]. By 28 days in culture
the de novo cells appeared to be forming a continuous layer
along the articular surface between the damage ﬁssures
[Fig. 2(B)].
Towards the end of the culture period some de novo cells
were also observed along the cut edges of both impacted
and unimpacted cartilage, indicating a response to damage
caused by dissection.
No differences in damage response were apparent in this
study between cartilage from different aged animals or from
different joints.
The de novo cells were shown by immunohistochemistry
to be producing PGs, collagens types II and IX/XI but not
539Osteoarthritis and Cartilage Vol. 13, No. 6Fig. 1. Effect of a single impact load (500 g from 2.5 cm) on articular cartilage. (A) Impact causes surface roughening. Scale barZ 10 mm. (B)
Impact causes formation of deep 45( ﬁssures. Scale barZ 10 mm. (C) Articular cartilage after 7 days in culture. Impact causes multiple ﬁssure
formation. Scale barZ 10 mm. (D) Control section with no impact load applied. Scale barZ 10 mm. All sections stained with Toluidine blue.type I11,12, and were therefore assumed to be chondro-
cytes.
EFFECT OF FGF-2 ON THE ENDOGENOUS REPAIR RESPONSE
FGF-2 at the lower concentrations of 12 and 25 ng/ml had
little effect on the number of de novo cells, but present at 50
and 100 ng/ml, it was noted that considerably increased
numbers of de novo cells were present on the impacted
cartilage and that there was evidence of clonal proliferation
in the cartilage underlying the articular surface (considered
as multiple nuclei within a single lacuna and evidence of
mitotic bodies [Fig. 3(A)]). In addition, a number of cellswithin the ECM were noted to have an altered phenotype,
having an elongated spindle shape instead of the usual
rounded chondrocyte shape. These spindle-shaped cells
were often orientated towards the articular surface and, in
some instances, appeared to represent cells migrating out
onto the surface [Fig. 3(B)].
At these higher concentrations of FGF-2 some depletion
of PG from the extracellular matrix was apparent in
some samples, as assessed by loss of staining with Tolu-
idine blue [Fig. 3(A,B)]. This was not a consistent ﬁnding,
however. More evident was the reproducible strong
staining of the de novo cells, indicating continuing pro-
duction of PG.Fig. 2. Articular cartilage following impact, showing response to damage. (A) After 21 days in culture post-impact (0 ng/ml FGF-2) showing
de novo cells at the site of ﬁssure damage. Stained with H&E. Scale barZ 160 mm. (B) After 28 days in culture post-impact (0 ng/ml FGF-2)
showing de novo cells covering the articular surface. Immunohistochemical staining with antiserum to collagen type IX/XI. Scale barZ 100 mm.
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Fig. 4(A) shows the change with time in the mean number
of de novo cells present on the articular surface of impacted
and non-impacted (control) cartilage in response to different
concentrations of FGF-2 during in vitro culture. At day 1 in
culture no de novo cells were present on impacted cartilage
explants cultured either in the presence or absence of
FGF-2. De novo cells were ﬁrst detected, in small numbers,
after 3 days in culture post-impact [Fig. 4(B)] in the
presence of 50 and 100 ng/ml FGF-2. At lower concen-
trations of FGF-2 (12 and 25 ng/ml), and in controls (0 ng/ml
FGF-2), no de novo cells were detected on cartilage until
after day 10. By 20e28 days in culture with low concen-
trations of FGF-2 small numbers of de novo cells began to
appear also at the cut edges of impacted and non-impacted
cartilage, as described above. This delayed increase in cell
numbers was insigniﬁcant compared to the dramatic
increase caused by FGF-2 from day 7 onwards.
From 7 days in culture onwards a statistically signiﬁcant
(PZ 0.018) increase in the numbers of de novo cells was
detected on impacted cartilage explants cultured in the
presence of 50 and 100 ng/ml FGF-2 [Fig. 4(C)], com-
pared to lower doses of FGF-2 and to control explants
(0 ng/ml FGF-2) [Fig. 4(A)]. The effective concentration of
FGF-2 for promoting a highly signiﬁcant difference in de
novo cell numbers seemed to be 50 ng/ml. No discernable
Fig. 3. Articular cartilage following impact damage and cultured for
7 days in the presence of 50 ng/ml FGF-2. (A) A single layer of
de novo cells is present on the articular surface of the cartilage. In
the cartilage beneath the articular surface, cells appear to be
undergoing mitosis (arrow) and clonal expansion (white arrows).
Scale barZ 45 mm. Stained with Toluidine blue. (B) A number of
spindle-shaped cells are apparent immediately below the de novo
cells. Scale barZ 45 mm. Stained with Toluidine blue.difference in de novo cell numbers was noted between 50
and 100 ng/ml FGF-2.
In unimpacted FGF-2 treated (50 ng/ml) controls de novo
cells were present after day 7 but their numbers were
signiﬁcantly lower than the corresponding impacted sam-
ples [Fig. 4(A)].
At 28 days the numbers of de novo cells at these lower
doses (mean 5.9 cells observed per!20 ﬁeld) were similar
to the numbers detected in the presence of 50 and 100 ng/
ml at day 7 (mean 7.3 cells observed per!20 ﬁeld), clearly
demonstrating the acceleration in response due to FGF-2.
These FGF-2 time-course and doseeresponse experi-
ments were performed with impacted cartilage samples
from eight different aged horses. Unimpacted cartilage from
four of these horses served as controls. Since no signiﬁcant
age differences were noted, data from the individual
experiments were pooled to provide the plot in Fig. 4(A).
CHARACTERISATION OF DE NOVO CELLS
Immunohistochemical staining revealed that the de novo
cells stained positively for collagen type II [Fig. 5(A)] and
collagen types IX/XI [Fig. 5(B)]. Importantly no staining was
detected for collagen type I, a marker of the ﬁbroblastic
phenotype. In addition, the de novo cells also stained
strongly for the marker of cell proliferation, PCNA and for
the CPC marker, Notch-1 [Fig. 5(C,D)]. The spindle-shaped
cells in the cartilage underlying the articular surface were
also stained strongly by anti-collagen type II, collagen types
IX/XI [Fig. 5(A,B)], weakly by anti-Notch antiserum and not
at all by anti-collagen type I antiserum.
Discussion
The data reported here indicate that FGF-2 signiﬁcantly
accelerates the appearance, and increases the numbers, of
de novo cells identiﬁed histologically in this experimental
model of endogenous cartilage repair. This response
depends on the concentration of FGF-2, with little effect
being seen at less than 50 ng/ml. Such dose-responsive-
ness of chondrocytes to FGF-2 has been previously
reported in other experimental systems27.
The de novo cells described here and by Bowe and
coworkers11,12, must, by experimental design, be of
cartilage origin, as no synovial tissue or underlying bone
was included in the harvested explants. These cells, and
the underlying spindle-shaped cells are Notch-1 and PCNA
immunopositive. Cells immunopositive for PCNA are
considered to be actively proliferating, whilst Notch-1 is
reported to be a marker for chondroprogenitor cells6,10. The
results reported here thus provide further evidence for the
presence of CPC in articular cartilage and indicate that CPC
may be identiﬁable, under certain conditions, in mature
articular cartilage, in addition to neonatal cartilage as
previously described6. In this experimental system the
cartilage has been stimulated by both mechanical damage
and FGF-2. Our results, and those reported by Bowe and
coworkers12, show that mechanical damage induces the
appearance of de novo cells, whilst FGF-2 clearly accel-
erates and potentiates the response.
Histologically, these results provide evidence that FGF-2
is stimulating de novo cell production. The de novo cells
appear to be derived from division of cells in the area of
cartilage immediately underlying the articular surface. In this
region there is evidence of mitosis and numbers of cells are
seen undergoing clonal expansion. We would speculate
541Osteoarthritis and Cartilage Vol. 13, No. 6Fig. 4. Time-course and doseeresponse of FGF-2 in impacted and unimpacted articular cartilage. (A) Mean number of de novo cells
(Gstandard deviations) detected at the articular surface of cartilage explants in the presence of various concentrations of FGF-2. Each
experimental point represents summed data from eight horses (impacted cartilage) and from four horses (unimpacted cartilage). (B) A small
number of de novo cells on the surface of the articular cartilage after 3 days in culture post-impact in the presence of 50 ng/ml FGF-2.
Scale barZ 20 mm. (C) Increased numbers of de novo cells on the surface of the articular cartilage after 7 days in culture post-impact in the
presence of 50 ng/ml FGF-2. Scale barZ 20 mm.that these cells then migrate out onto the surface of the
cartilage, in response to the combined effect of damage and
FGF-2 treatment, presumably to initiate repair. Evidence of
such a repair response was provided by the location of the
de novo cells that appeared to be coating the damaged
articular surface and lining the ﬁssures in an apparent
attempt to repair the damage. It is interesting that, in
addition to increasing cell numbers, FGF-2 has been
implicated in the potentiation of migration of chondrocytes
in monolayer culture in vitro, enhancing the velocity of cell
migration28.
These induced de novo cells are phenotypically chon-
drocytes, as demonstrated by their positive staining for the
chondrocyte markers, PG, and collagen types II29, IX/XI30.In another study (unpublished observations) we have also
shown that the chondrocyte-speciﬁc cartilage matrix com-
ponents ﬁbronectin31 and Cartilage oligomeric matrix pro-
tein (COMP)30 are also expressed by these cells. No
staining for type I collagen was detected. This is signiﬁcant
as collagen type I is a marker of a ﬁbroblastic phenotype,
rather than a chondrocytic phenotype, thus indicating that
the spindle-shaped cells (which are likely to represent cells
undergoing migration through the ECM) had a chondrocyte
phenotype. Additionally, it can be concluded that in this
study, incubation with FGF-2 at concentrations up to
100 ng/ml for up to 28 days did not induce a change from
a chondrocytic phenotype to a ﬁbroblastic phenotype. This
result is in agreement with other workers who previously
542 F. M. D. Henson et al.: FGF-2 promotion of damageerepair response in articular cartilageFig. 5. Characterisation of de novo cells on the surface of the articular cartilage after 7 days in culture post-impact in the presence of 50 ng/ml
FGF-2. (A) Immunolocalisation with anti-type II collagen antiserum. The cartilage extracellular matrix and the de novo cells are positively
stained. Scale barZ 45 mm. (B) Immunolocalisation with anti-type IX/XI collagen antiserum. The cartilage extracellular matrix and the de novo
cells are positively stained, as are the spindle-shaped cells underneath the articular surface. Scale barZ 35 mm. (C) Immunolocalisation was
performed with anti-PCNA antiserum. Positive staining is present within the de novo cells and within cells underlying the articular surface.
Scale barZ 150 mm. (D) Immunolocalisation was performed with anti-Notch-1 antiserum. Positive staining is present within the dividing cells
within the cartilage and, to a lesser extent, in the de novo cells. Scale barZ 100 mm.reported that FGF-2 had a stabilising effect on the
differentiated chondrocyte phenotype in an agarose repair
model19. Mandl et al.32 also demonstrated that FGF-2-
stimulated-chondrocytes had a better re-differentiation
capacity and produced less type I collagen than cells
treated with other growth factors. We suggest that these
chondrocytes, which re-located to sites of impact damage,
are capable of synthesising cartilage matrix components
and thus have the potential for cartilage repair.
Connective tissue stem cells are known to be a target for
FGF-2; in full thickness defects in vivo, FGF-2 stimulates
prechondrogenic mesenchymal cells, giving rise to selec-
tive clonal expansion18. It has been reported that FGF-2 is
the most effective growth factor for promoting growth of
bone-marrow stromal cells in vitro20 and that FGF-2 plays
a crucial role in the self-renewal of these MSC33. The
demonstration of a restricted zone of proliferating Notch-1
positive cells immediately beneath the articular surface of
damaged, FGF-2 treated cartilage conﬁrms both the
presence and location of CPC. Although we might
speculate that these are the cells that migrate out to sites
of damage, the mechanism of action of FGF-2 on CPC and
cell migration is as yet unknown. FGF-2 stimulates a wide
response from target cells, including, in cartilage, the
activation of the extra-cellular signal-regulated kinase 1/2and p38 MAPK pathways34. In this experimental model
FGF-2 may be acting, in part, via SOX-9, a transcription
factor essential for chondrocyte differentiation and cartilage
formation27,35. FGF-2 is a particularly potent agonist in this
process36, increasing SOX-9 expression through all four
FGF-receptors via an MAPK regulatory pathway37.
The results of this study, together with those previously
reported by our group (Bowe and coworkers12) indicate
that, following a single impact load, CPC can be stimulated
in mature articular cartilage in vitro. These CPC and the
cells arising from them represent the cartilage’s repair
response to damage. The timing of the appearance of CPC
and their overall numbers can be signiﬁcantly increased by
FGF-2, providing further evidence for an important role for
FGF-2 in modulating cartilage repair. These results indicate
that further study into the mechanisms of repair in mature
cartilage using this in vitro model may be vital in
understanding the repair capacity of mature cartilage.
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